Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $30.3300 (0.43%) ($29.7200 - $31.1000) on Thu. Jul. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.71% (three month average) | RSI | 53 | Latest Price | $30.3300(0.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.2% a day on average for past five trading days. | Weekly Trend | EDIT declines -2.3% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(61%) IWO(58%) ARKG(56%) IBUY(54%) IWC(54%) | Factors Impacting EDIT price | EDIT will decline at least -2.355% in a week (0% probabilities). VIXM(-28%) UUP(-15%) VXX(-12%) TBT(-7%) IYT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.355% (StdDev 4.71%) | Hourly BBV | 0 () | Intraday Trend | 0.4% | | | |
|
Resistance Level | $31.48 | 5 Day Moving Average | $31.13(-2.57%) | 10 Day Moving Average | $31.6(-4.02%) | 20 Day Moving Average | $31.48(-3.65%) | To recent high | -12.4% | To recent low | 36.6% | Market Cap | $1.884b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |